Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma

This cohort study examines the clinical efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced malignant peritoneal mesothelioma.

Detalles Bibliográficos
Autores principales: Raghav, Kanwal, Liu, Suyu, Overman, Michael, Morani, Ajaykumar, Willette, Anneleis, Fournier, Keith, Varadhachary, Gauri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346939/
https://www.ncbi.nlm.nih.gov/pubmed/34357397
http://dx.doi.org/10.1001/jamanetworkopen.2021.19934
_version_ 1783734963234930688
author Raghav, Kanwal
Liu, Suyu
Overman, Michael
Morani, Ajaykumar
Willette, Anneleis
Fournier, Keith
Varadhachary, Gauri
author_facet Raghav, Kanwal
Liu, Suyu
Overman, Michael
Morani, Ajaykumar
Willette, Anneleis
Fournier, Keith
Varadhachary, Gauri
author_sort Raghav, Kanwal
collection PubMed
description This cohort study examines the clinical efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced malignant peritoneal mesothelioma.
format Online
Article
Text
id pubmed-8346939
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-83469392021-08-20 Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma Raghav, Kanwal Liu, Suyu Overman, Michael Morani, Ajaykumar Willette, Anneleis Fournier, Keith Varadhachary, Gauri JAMA Netw Open Research Letter This cohort study examines the clinical efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced malignant peritoneal mesothelioma. American Medical Association 2021-08-06 /pmc/articles/PMC8346939/ /pubmed/34357397 http://dx.doi.org/10.1001/jamanetworkopen.2021.19934 Text en Copyright 2021 Raghav K et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Raghav, Kanwal
Liu, Suyu
Overman, Michael
Morani, Ajaykumar
Willette, Anneleis
Fournier, Keith
Varadhachary, Gauri
Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma
title Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma
title_full Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma
title_fullStr Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma
title_full_unstemmed Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma
title_short Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma
title_sort clinical efficacy of immune checkpoint inhibitors in patients with advanced malignant peritoneal mesothelioma
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346939/
https://www.ncbi.nlm.nih.gov/pubmed/34357397
http://dx.doi.org/10.1001/jamanetworkopen.2021.19934
work_keys_str_mv AT raghavkanwal clinicalefficacyofimmunecheckpointinhibitorsinpatientswithadvancedmalignantperitonealmesothelioma
AT liusuyu clinicalefficacyofimmunecheckpointinhibitorsinpatientswithadvancedmalignantperitonealmesothelioma
AT overmanmichael clinicalefficacyofimmunecheckpointinhibitorsinpatientswithadvancedmalignantperitonealmesothelioma
AT moraniajaykumar clinicalefficacyofimmunecheckpointinhibitorsinpatientswithadvancedmalignantperitonealmesothelioma
AT willetteanneleis clinicalefficacyofimmunecheckpointinhibitorsinpatientswithadvancedmalignantperitonealmesothelioma
AT fournierkeith clinicalefficacyofimmunecheckpointinhibitorsinpatientswithadvancedmalignantperitonealmesothelioma
AT varadhacharygauri clinicalefficacyofimmunecheckpointinhibitorsinpatientswithadvancedmalignantperitonealmesothelioma

Ejemplares similares